Cargando…

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart

BACKGROUND: NOD-like receptors (NLR) are intracellular sensors of the innate immune system, with the NLRP3 being a pro-inflammatory member that modulates cardiac ischemia-reperfusion injury (IRI) and metabolism. No information is available on a possible role of anti-inflammatory NLRs on IRI and meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hong, Xiao, Yang, Nederlof, Rianne, Bakker, Diane, Zhang, Pengbo, Girardin, Stephen E., Hollmann, Markus W., Weber, Nina C., Houten, Sander M., van Weeghel, Michel, Kibbey, Richard G., Zuurbier, Coert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759503/ https://www.ncbi.nlm.nih.gov/pubmed/33362773 http://dx.doi.org/10.3389/fimmu.2020.591815

Ejemplares similares

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
por: Xiao, Yang, et al.
Publicado: (2021)

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
por: Xiao, Yang, et al.
Publicado: (2021)

Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts
por: Zhang, Hong, et al.
Publicado: (2020)

Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart
por: Nederlof, Rianne, et al.
Publicado: (2017)

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy
por: Wang, Qian, et al.
Publicado: (2023)

NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity
por: Stokman, Geurt, et al.
Publicado: (2017)

A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients
por: Nederlof, Rianne, et al.
Publicado: (2017)

Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity
por: Nederlof, Rianne, et al.
Publicado: (2017)

Modeling-Enabled Characterization of Novel NLRX1 Ligands
por: Lu, Pinyi, et al.
Publicado: (2015)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

Direct cardiac effects of SGLT2 inhibitors
por: Chen, Sha, et al.
Publicado: (2022)

Partial hexokinase II knockout results in acute ischemia–reperfusion damage in skeletal muscle of male, but not female, mice
por: Smeele, Kirsten M., et al.
Publicado: (2010)

The Mitochondrial Protein NLRX1 Controls the Balance between Extrinsic and Intrinsic Apoptosis
por: Soares, Fraser, et al.
Publicado: (2014)

NLRX1/FUNDC1/NIPSNAP1‐2 axis regulates mitophagy and alleviates intestinal ischaemia/reperfusion injury
por: Li, Shaoqin, et al.
Publicado: (2021)

Male Mice Lacking NLRX1 Are Partially Protected From High-Fat Diet–Induced Hyperglycemia
por: Costford, Sheila R, et al.
Publicado: (2018)

Cardioprotective efficacy depends critically on pharmacological dose, duration of ischaemia, health status of animals and choice of anaesthetic regimen: a case study with folic acid
por: Zuurbier, Coert J, et al.
Publicado: (2014)

Nlrx1 regulates neuronal cell death
por: Imbeault, Emilie, et al.
Publicado: (2014)

Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori Infection
por: Philipson, Casandra W., et al.
Publicado: (2015)

Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
por: Li, Xiaoling, et al.
Publicado: (2021)

Reduced acute myocardial ischemia–reperfusion injury in IL-6-deficient mice employing a closed-chest model
por: Jong, Willeke M. C., et al.
Publicado: (2016)

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
por: Zuurbier, Coert J.
Publicado: (2020)

Remote Ischemic Conditioning to Protect against Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis
por: Brevoord, Daniel, et al.
Publicado: (2012)

NLRX1 Regulation Following Acute Mitochondrial Injury
por: Chu, Xiaogang, et al.
Publicado: (2019)

Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
por: Zuurbier, Coert J., et al.
Publicado: (2012)

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
por: Uthman, Laween, et al.
Publicado: (2018)

Focusing on the Cell Type Specific Regulatory Actions of NLRX1
por: Fekete, Tünde, et al.
Publicado: (2021)

NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin
por: Scantlebery, Angelique M. L., et al.
Publicado: (2019)

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
por: Uthman, Laween, et al.
Publicado: (2020)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

NLRX1 Enhances Glutamate Uptake and Inhibits Glutamate Release by Astrocytes
por: Mahmoud, Shaimaa, et al.
Publicado: (2019)

NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function
por: Nagai-Singer, Margaret A., et al.
Publicado: (2019)

Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia–induced cell damage
por: Weber, Nina C., et al.
Publicado: (2015)

Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1
por: Smit, Kirsten F., et al.
Publicado: (2018)

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation
por: Uthman, Laween, et al.
Publicado: (2017)

NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2017)

NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis
por: Kastelberg, Bridget, et al.
Publicado: (2020)

NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity
por: Gharagozloo, Marjan, et al.
Publicado: (2019)

Morphine-induced microglial immunosuppression via activation of insufficient mitophagy regulated by NLRX1
por: Peng, Jialing, et al.
Publicado: (2022)

NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells
por: Nagai-Singer, Margaret A., et al.
Publicado: (2023)

Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury
por: Stroethoff, Martin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p3v99a9hdj9h1n0u5m2399s1sm